Tag: Protagonist Therapeutics Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Protagonist Therapeutics Inc

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Expected to Announce Earnings of -$0.40 Per Share

Added to Collection on: 2021-06-14 19:07:30

Tags for this article:

Finance
Financial markets
Financial ratios
Corporate finance
Money
Stock market
Fundamental analysis
Price?earnings ratio
ANGI Homeservices
Earnings per share
Stock
Protagonist Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Protagonist Therapeutics Announces Proposed Public Offering of Common Stock

Added to Collection on: 2021-06-14 21:02:47

Tags for this article:

Initial public offering
Finance
Financial economics
Financial markets
Stock market
U.S. Securities and Exchange Commission
Prospectus
Corporate finance
Shelf registration
Forward-looking statement
Public offering
Registration statement
Protagonist Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax ...

Added to Collection on: 2021-06-15 12:07:43

Tags for this article:

Life Sciences
Companies
Industry economics)
Medical research
NASDAQ
Biogen
Novavax
AstraZeneca
COVID-19 vaccine
Vertex Pharmaceuticals
NASDAQ-100
Protagonist Therapeutics Inc
ResMed Inc.
Maravai LifeSciences Holdings, Inc.
DR.REDDY'S LABORATORIES LIMITED
Enochian Biosciences Inc.
Sesen Bio Inc.
Alkermes Plc
GT Biopharma Inc.
Centessa Pharmaceuticals Limited
Jazz Pharmaceuticals PLC
RDY Edwards Lifesciences Corporation
Verastem Inc.
Dicerna Pharmaceuticals Inc
LeMaitre Vascular Inc.
Zoetis Inc.
PPD, Inc.
Apellis Pharmaceuticals Inc.
NovoCure Limited
RAPT Therapeutics Inc.
Ortho Clinical Diagnostics Holdings plc
Koninklijke Philips NV
Psychemedics Corporation
Shockwave Medical Inc
Bio-Techne Corporation

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine ...

Added to Collection on: 2021-06-17 12:31:23

Tags for this article:

Life Sciences
Industry economics)
Companies
Economy of New York City
NASDAQ
Biogen
Genmab
Pfizer
CureVac
Alnylam Pharmaceuticals
Protagonist Therapeutics Inc
Happiness Biotech Group Limited
DR.REDDY'S LABORATORIES LIMITED
Misonix Inc.
SATSUMA's
Alexion Pharmaceuticals Inc.
Kindred Biosciences Inc
Spruce Biosciences Inc.
ORIC Pharmaceuticals Inc.
Alzamend Neuro Inc.
LeMaitre Vascular Inc.
Zoetis Inc.
Vertex Pharmaceuticals Incorporated
Study Satsuma Pharmaceuticals, Inc.
Genmab A/S
Prometheus Biosciences Inc.
Aptose Biosciences Inc
Pharming Group N.V.
AbCellera Biologics Inc.
Natus Medical Incorporated
Shockwave Medical Inc
Inhibikase Therapeutics Inc.
Citius Pharmaceuticals Inc
Supernus Pharmaceuticals Inc
Yumanity Therapeutics Inc.
Elanco Animal Health Incorporated

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 ...

Added to Collection on: 2021-06-18 11:46:20

Tags for this article:

Companies
Life Sciences
Industry economics)
Economy of New York City
NASDAQ
Bristol-Myers Squibb
BioNTech
BeiGene
Protagonist Therapeutics Inc
Kindred Biosciences Inc
10x genomics inc
Clearside Biomedical Inc
LeMaitre Vascular Inc.
Portage Biotech Inc.
NovoCure Limited
Natus Medical Incorporated
Bio-Techne Corporation
Citius Pharmaceuticals Inc

Click the tags to see associated articles and topics

View Article Details
Bingham Osborn & Scarborough Llc Buys SPDR MSCI EAFE Fossil Fuel Reserves Free ETF ...

Added to Collection on: 2021-08-02 23:37:30

Tags for this article:

Exchange-traded funds
Finance
Financial markets
Investment
IShares
SPDR
MSCI EAFE
MSCI
Berkshire Hathaway
Protagonist Therapeutics Inc
Dover Corp
Bingham Osborn
OSBORN & SCARBOROUGH LLC
iShares Gold Trust

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 ...

Added to Collection on: 2021-08-05 12:00:00

Tags for this article:

Finance
Pharmaceutical companies
Economy of New York City
NASDAQ
Financial markets
Alnylam Pharmaceuticals
Dow Jones Industrial Average
Arbutus Biopharma
NASDAQ-100
Nasdaq, Inc.
Maravai LifeSciences Holdings, Inc.
AbSci CORP
Novo Nordisk A/S
Alkermes Plc
Innoviva Inc
Sanofi
Cytek Biosciences Inc.
Horizon Therapeutics Public Limited Company
Eli Lilly and Company
DexCom Inc.
Bio-Rad Laboratories Inc.
Laboratory Corporation of America Holdings
Myriad Genetics Inc.
Translate Bio Inc
Protagonist Therapeutics Inc
ResMed Inc.
Edwards Lifesciences Corporation
BeyondSpring Inc.
Monte Rosa Therapeutics Inc.
Nuvalent Inc.
REPLIGEN CORPORATION
Alnylam Pharmaceuticals Inc.
BioNTech SE
Johnson & Johnson
Bristol-Myers Squibb Company
Zoetis Inc.
Genmab A/S
Moderna, Inc.
Impel NeuroPharma Inc.
Quest Diagnostics Incorporated
Immuneering Corporation
Intuitive Surgical Inc

Click the tags to see associated articles and topics

View Article Details
Parkman Healthcare Partners LLC Buys Intuitive Surgical Inc, Repligen Corp, Seagen Inc, Sells ...

Added to Collection on: 2021-08-16 22:55:30

Tags for this article:

Companies
General Electric
RCA
Schenectady, New York
Thomas Edison
Economy of the United States
Industry economics)
Protagonist Therapeutics Inc
Amgen Inc.
Nevro Corp.
Nuance Communications Inc.
Seagen Inc.
Vericel Corp
Avid Bioservices Inc.
Repligen Corp
Arrowhead Pharmaceuticals Inc.
Intuitive Surgical Inc

Click the tags to see associated articles and topics

View Article Details
-$0.67 EPS Expected for Protagonist Therapeutics, Inc. (NASDAQ:PTGX) This Quarter | MarketBeat

Added to Collection on: 2021-09-02 13:18:45

Tags for this article:

Finance
Money
Financial markets
Financial ratios
Corporate finance
Fundamental analysis
Stock market
Price?earnings ratio
ANGI Homeservices
Earnings per share
Short
Stock
Protagonist Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Protagonist Therapeutics shares slid after sharing Phase 2 data for its experimental ... - MarketWatch

Added to Collection on: 2022-04-26 12:44:05

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Monoclonal antibodies
Diarrhea
Immunosuppressants
Vedolizumab
Colitis
Autoimmune diseases
Ulcerative colitis
Clinical endpoint
Protagonist Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details